Table 4.
Position | −909 | −162 | −108 | No. ofCases | Mean ±SDArylesteraseActivity(U/ml) | P |
−909 | CC | GG | CT | 20 | 96.0 ± 41.5 | .959 |
CG | GG | CT | 83 | 96.5 ± 35.8 | ||
−162 | CG | AG | CT | 80 | 109.3 ± 36.9 | .026 |
CG | GG | CT | 83 | 96.5 ± 35.8 | ||
−108 | CC | GG | CT | 20 | 96.0 ± 41.5 | .009 |
CC | GG | TT | 86 | 68.2 ± 28.1 | ||
All three | GG | AA | CC | 14 | 140.9 ± 52.7 | <.001 |
CG | AG | CT | 80 | 109.3 ± 36.9 | ||
CC | GG | TT | 86 | 68.2 ± 28.1 |